Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret (IS:ANGEN) — Market Cap & Net Worth
Market Cap & Net Worth: Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret (ANGEN)
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret (IS:ANGEN) has a market capitalization of $38.04 Million (TL1.70 Billion) as of September 21, 2026. Listed on the IS stock exchange, this Turkey-based company holds position #23027 globally and #368 in its home market, demonstrating a -14.60% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret's stock price TL7.72 by its total outstanding shares 220000000 (220.00 Million). Also see total assets of Anatolia Tani ve Biyoteknoloji Urunleri for a full breakdown of the balance sheet.
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Market Cap History: 2021 to 2026
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret's market capitalization history from 2021 to 2026. Data shows change from $62.69 Million to $38.04 Million (-6.57% CAGR). Also see ANGEN cash flow metrics for how efficiently the company converts equity into cash flow.
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check current stock price of Anatolia Tani ve Biyoteknoloji Urunleri for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.11x
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret's market cap is 0.11 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $62.69 Million | $410.11 Million | $433.33 Million | 0.15x | 0.14x |
| 2022 | $101.07 Million | $268.82 Million | $330.39 Million | 0.38x | 0.31x |
| 2023 | $61.35 Million | $343.92 Million | -$197.32 Million | 0.18x | N/A |
| 2024 | $60.90 Million | $529.83 Million | -$218.88 Million | 0.11x | N/A |
Competitor Companies of ANGEN by Market Capitalization
Companies near Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret in the global market cap rankings as of September 21, 2026. Review Anatolia Tani ve Biyoteknoloji Urunleri tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #124 globally with a market cap of $178.43 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #238 globally with a market cap of $105.53 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #124 | Abbott Laboratories | NYSE:ABT | $178.43 Billion | $102.61 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.13 |
| #238 | Stryker Corporation | NYSE:SYK | $105.53 Billion | $275.12 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Historical Marketcap From 2021 to 2026
Between 2021 and today, Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret's market cap moved from $62.69 Million to $ 38.04 Million, with a yearly change of -6.57%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | TL38.04 Million | -28.58% |
| 2025 | TL53.27 Million | -12.54% |
| 2024 | TL60.90 Million | -0.72% |
| 2023 | TL61.35 Million | -39.30% |
| 2022 | TL101.07 Million | +61.21% |
| 2021 | TL62.69 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 20th, 2026 the market cap of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $38.04 Million USD |
| MoneyControl | $38.04 Million USD |
| MarketWatch | $38.04 Million USD |
| marketcap.company | $38.04 Million USD |
| Reuters | $38.04 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret
Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S., a biotechnology company, engages in the design, development, and manufacture of real-time PCR kits, nucleic acid extraction kits, and automated nucleic acid extraction instruments in Turkey. It offers microbiology, genetic disorder, panel, sequencing, and food testing kits; and manual spin column and magnetic bead nucleic acid ext… Read more